ArticleJournal of neurology2026
Brain-first versus body-first Parkinson's disease: Differential findings on pupillary, brainstem and vagus sonography.
Article in Journal of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundIn Parkinson's disease (PD), two pathogenetic subtypes have been proposed: a 'brain-first', with α-synuclein pathology arising in one hemisphere and spreading secondarily to the peripheral autonomic nervous system, and a 'body-first' subtype, with the pathology originating in the enteric or peripheral autonomic nervous system and subsequently spreading symmetrically to the brain. To dissect these subtypes, we assessed the association between pupillary dysfunction, mesencephalic raphe and substantia nigra changes, vagus nerve atrophy and vagal electrocardiographic parameters in PD patients and controls.
methodsIn this single-center cross-sectional study, we included 54 people with PD and 60 matched healthy controls. Participants underwent clinical assessments, electrocardiography, and sonographic measurements of substantia nigra echoic area, midbrain raphe echo-score and vagus nerve caliber. Dynamic ultrasound pupillometry was performed in drug-naïve de novo PD patients and matched controls. The brain-first and body-first subtypes were classified based on the REM-sleep Behavior Disorder Screening Questionnaire and gastrointestinal symptoms.
resultsVagal atrophy increased with disease duration and severity. During the first decade of motor disease, vagal atrophy and dysfunction occurred in body-first but not brain-first PD. Sympathetic pupillary innervation was reduced in de novo body-first but not brain-first PD patients. However, parasympathetic pupillary innervation was reduced in both subtypes at the de novo stage. Substantia nigra hyperechoic area was asymmetrical in brain-first but more symmetrical in body-first PD.
conclusionsOur findings support the concept of two subtypes of PD in which the mesencephalic and vagal parasympathetic systems are affected in opposite sequences. Ultrasonic and electrocardiographic examination could facilitate early subtyping.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.